Resultado da Busca
6 de ago. de 2021 · The rapid development of COVID-19 vaccines has had a profound effect on the world. As the large scale rollout continues around the world, with 4.32 billion doses administered, new challenges remain around variants including Delta, consumer acceptance and vaccination rates, and global equity.
21 de mai. de 2021 · More than a year after the COVID-19 pandemic began, a line of sight exists that promises enough vaccine for every eligible adult in the United States. This breakthrough offers hope, but also underscores an urgent need to plan the next phase of distribution and beyond.
24 de abr. de 2021 · Vaccine rollout and immunization. The risks and challenges of the global COVID-19-vaccine rollout. “Getting shots into arms”: How US states are addressing the vaccine distribution challenge. ‘None are safe until all are safe’—COVID-19 vaccine rollout in low- and middle-income countries.
- Critical Emerging Risks
- Collaborative Approaches to Help Mitigate Emerging Risks
- Managing Risks at The Interface Among Organizations
The common operating model provides the details of end-to-end vaccine deployment. From this model, we have highlighted six possible areas of risk to the rapid delivery of COVID-19 vaccines in the United States and elsewhere. In a later section, we outline possible approaches to mitigating each of these risks, with practical steps for organizations ...
There are several possible approaches to help mitigate each of the six risks discussed, each with practical steps for organization to take across the common operating model.
Although none of the many organizations involved is solely responsible for managing vaccine deployment across the common operating model, the risks can be more fully addressed with increased stakeholder cooperation. To build this collaboration, working groups could meet to identify the various risks, assess their likelihood and potential impact, an...
6 de fev. de 2021 · The risks and challenges of the global COVID-19-vaccine rollout. A realistic assessment of the heroic effort to administer billions of doses of COVID-19 vaccines to an agonized global population is necessary—the stakes could not be higher. Manage the risks. Organizing for the future: Nine keys to becoming a future-ready company.
During a McKinsey Live webinar, partners Tania Holt and Adam Sabow addressed six pressing questions related to vaccine delivery and adoption: What’s the latest on vaccine development? What are the implications of the new virus strains? How is the rollout expected to work? How is it going so far? When will the pandemic end?
29 de abr. de 2021 · Several developed nations have been successful in their vaccine rollout, including the US, Israel, the UAE and the UK. However, some developed countries are lagging behind due to logistical challenges, according to a new McKinsey and World Economic Forum report.
